Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts
Kidney Int Rep
.
2025 Jan 20;10(4):1283-1287.
doi: 10.1016/j.ekir.2025.01.025.
eCollection 2025 Apr.
Authors
Sean J Barbour
1
2
,
Rosanna Coppo
3
,
Jonathan Barratt
4
,
Lee Er
2
,
Richard Lafayette
5
,
Hiddo J L Heerspink
6
,
Dana V Rizk
7
,
Adrian Liew
8
,
Vivekanand Jha
9
10
11
,
Hong Zhang
12
,
Yusuke Suzuki
13
,
Hernan Trimarchi
14
,
Daniel C Cattran
15
;
International IgA Nephropathy Network Research Group
Affiliations
1
Division of Nephrology, University of British Columbia, British Columbia, Vancouver, Canada.
2
BC Renal, Vancouver, Canada.
3
Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
4
Cardiovascular Sciences, University of Leicester, Leicester, UK.
5
Stanford University Medical Center, Stanford, California, USA.
6
Department Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.
7
University of Alabama at Birmingham, Birmingham, Alabama, USA.
8
Mount Elizabeth Novena Hospital, Singapore.
9
George Institute for Global Health, New Delhi, India.
10
School of Public Health, Imperial College, London, UK.
11
Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
12
Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
13
Juntendo University, Faculty of Medicine, Tokyo, Japan.
14
Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
15
Division of Nephrology, University of Toronto, Toronto, Ontario, Canada.
PMID:
40303195
PMCID:
PMC12034880
DOI:
10.1016/j.ekir.2025.01.025
No abstract available